Skip to content

PR push upcoming for Cold-EEZE

Cold remedy brand Cold-EEZE has signed on 5W Public Relations as its public relations agency. 5W Public Relations said Wednesday that it plans to launch a comprehensive, integrated public-relations program to promote Cold-EEZE in the consumer marketplace.

Table of Contents

NEW YORK — Cold remedy brand Cold-EEZE has signed on 5W Public Relations as its public relations agency.

5W Public Relations said Wednesday that it plans to launch a comprehensive, integrated public-relations program to promote Cold-EEZE in the consumer marketplace. Key elements will include media relations, celebrity integrations, co-branded partnerships and special events.

Made by Doylestown, Pa.-based ProPhase Labs Inc., Cold-EEZE is the No. 1 pharmacist-recommended zinc cold remedy, the PR agency said. Its proprietary formula (zinc gluconate) is believed by researchers to interfere with the cold virus’ ability to reproduce. In addition, Cold-EEZE uses natural flavors and has no preservatives or artificial colors. The over-the-counter medicine also is nondrowsy and nonagitating and doesn’t affect blood pressure.

The remedy reduces the duration and symptoms of the common cold, including cough, stuffy nose, sore throat, sneezing, post-nasal drip and hoarseness and "actually shortens your cold to help you get well sooner," according to the company.

"5WPR is extremely excited to be named PR agency of record for Cold-EEZE," stated Ronn Torossian, chief executive officer of 5W Public Relations. "We have seen tremendous growth in our consumer wellness division in the last few years and look forward to creating added awareness and excitement to the Cold-EEZE brand."

ProPhase Labs’ products include the Cold-EEZE and Kids-EEZE OTC remedy lines and Organix cough/cold drops. The products are carried by food, drug and mass merchandise chains and independent pharmacies nationwide.

Comments

Latest

FMI: Private brands take hold

FMI: Private brands take hold

Perceptions around private brands have changed; they are no longer seen merely as generics or national brand equivalents, Doug Baker, vice president, industry relations at FMI, said in releasing the report, titled “The Power of Private Brands 2024.”